Usefulness of thermography in the diagnosis and classification of complex regional pain syndrome.

Complex regional painful syndrome (CRPS) Dolor Pain Prueba sensorial cuantitativa (QST) Quantitative sensory test (QST) Síndrome de dolor regional complejo (SDRC) Termografía Thermography

Journal

Neurologia
ISSN: 2173-5808
Titre abrégé: Neurologia (Engl Ed)
Pays: Spain
ID NLM: 101778590

Informations de publication

Date de publication:
17 Dec 2020
Historique:
received: 21 08 2020
revised: 08 10 2020
accepted: 18 10 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 22 12 2020
Statut: aheadofprint

Résumé

We propose a protocol for study of complex regional pain syndrome (CRPS) based on a battery of quantitative measures (skin thermography, electrochemical skin conductance and sensory thresholds) and apply such protocol to 5 representative cases of CRPS. 5 CPRS cases (2 women/3 men) that met the Budapest criteria for the diagnosis of CRPS. All patients showed spontaneous pain and allodynia. Two cases correspond to a stage I, in both the resting basal temperature was increased in the affected limb. Three cases reflect more advanced stages with a decrease in resting temperature and a delay in the recovery of the temperature when compared to contralateral limb. These non-invasive quantitative functional tests not only improve the diagnostic accuracy of CRPS but also, they help us to stratify and understand the pathological processes of the disease.

Identifiants

DOI: 10.1016/j.nrl.2020.10.011 PMID: 33342641
pubmed: 33342641
pii: S0213-4853(20)30337-6
doi: 10.1016/j.nrl.2020.10.011
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

T Pérez-Concha (T)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain. Electronic address: tomas.perezconcha@osakidetza.eus.

B Tijero (B)

Autonomic Center (NeuroTek), San Juan de Dios Hospital, Santurtzi, Spain; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain; Department of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, Spain.

M Acera (M)

Autonomic Center (NeuroTek), San Juan de Dios Hospital, Santurtzi, Spain; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.

T Fernández (T)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain; Department of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, Spain.

I Gabilondo (I)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain; Ikerbasque: The Basque Foundation for Science, Bilbao, Spain.

J C Gómez-Esteban (JC)

Autonomic Center (NeuroTek), San Juan de Dios Hospital, Santurtzi, Spain; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain; Department of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, Spain. Electronic address: juancarlos.gomezesteban@osakidetza.eus.

Classifications MeSH